1
NSG 552 Psychopharmacology Exam 1 2 3 Wilkes
University Actual Exam 2026/2027 – Complete Exam-
Style Questions with Detailed Rationales | Pass
Guaranteed – A+ Graded
[EXAM 1: Neuropharmacology & Basic Principles — Questions 1-50]
Q1: Which of the following best describes the primary function of the synaptic cleft in
neurotransmission?
A. To synthesize neurotransmitters.
B. To store vesicles until release.
C. To allow diffusion of neurotransmitters from the presynaptic neuron to the postsynaptic
neuron. [CORRECT]
D. To degrade neurotransmitters via enzymatic breakdown.
Correct Answer: C
Rationale: The synaptic cleft is the physical gap between the presynaptic terminal button and the
postsynaptic membrane. Its primary function is to allow the neurotransmitter, once released, to
diffuse across to bind to receptors on the postsynaptic neuron. Synthesis occurs in the
soma/terminal (A); storage occurs in vesicles (B); degradation (D) occurs primarily in the cleft or
via reuptake, not as the structural purpose of the cleft itself.
Q2: A 28-year-old patient presents with a resting tremor, rigidity, and bradykinesia. Degeneration
of which specific dopamine pathway is most implicated in these symptoms?
A. Nigrostriatal pathway [CORRECT]
B. Mesolimbic pathway
C. Mesocortical pathway
D. Tuberoinfundibular pathway
Correct Answer: A
,2
Rationale: The nigrostriatal pathway projects from the substantia nigra to the basal ganglia and is
responsible for motor control. Degeneration of this pathway leads to the classic extrapyramidal
symptoms (EPS) seen in Parkinson's disease. The mesolimbic (B) is associated with reward and
psychosis; the mesocortical (C) with cognition and affect; the tuberoinfundibular (D) regulates
prolactin.
Q3: Which of the following correctly differentiates ionotropic receptors from metabotropic
receptors?
A. Ionotropic receptors are slow and use second messengers; metabotropic are fast and ligand-
gated.
B. Ionotropic receptors form an ion channel and produce fast synaptic transmission;
metabotropic receptors use G-proteins and second messengers for slower modulation.
[CORRECT]
C. Both receptors utilize second messenger systems.
D. Ionotropic receptors are primarily located presynaptically.
Correct Answer: B
Rationale: Ionotropic receptors (e.g., NMDA, GABA-A) are ligand-gated ion channels that allow
immediate ion flow across the membrane when a neurotransmitter binds, resulting in fast
synaptic transmission. Metabotropic receptors (e.g., GABA-B, 5-HT1A) are linked to G-proteins
and second messenger systems, producing slower, longer-lasting modulatory effects.
Q4: A PMHNP is treating a patient with depression. Which neurotransmitter is primarily
synthesized from the amino acid tryptophan and is heavily implicated in mood, sleep, and
appetite regulation?
A. Dopamine
B. Norepinephrine
C. Serotonin (5-HT) [CORRECT]
D. Acetylcholine
Correct Answer: C
,3
Rationale: Serotonin (5-HT) is synthesized from tryptophan. It plays a critical role in regulating
mood, anxiety, sleep, appetite, and impulse control. Dopamine (A) is synthesized from tyrosine;
Norepinephrine (B) is also synthesized from tyrosine; Acetylcholine (D) is synthesized from
choline and acetyl-CoA.
Q5: Which of the following CYP450 enzymes is responsible for the metabolism of the majority
of antidepressants and is known for its genetic polymorphism resulting in poor and ultrarapid
metabolizers?
A. CYP1A2
C. CYP2D6 [CORRECT]
B. CYP2C9
D. CYP3A4
Correct Answer: C
Rationale: CYP2D6 is highly polymorphic, with significant percentages of the population being
poor metabolizers (PMs) or ultrarapid metabolizers (UMs). It metabolizes many TCAs, SSRIs
(paroxetine, fluoxetine), and antipsychotics. CYP3A4 (D) is the most abundant but less
polymorphic; CYP1A2 (A) and CYP2C9 (B) have fewer substrates relevant to
psychopharmacology.
Q6: A patient prescribed a medication that is a strong CYP3A4 inhibitor (e.g., ketoconazole) is
experiencing toxicity from their existing antipsychotic. What is the pharmacokinetic
explanation?
A. The inhibitor decreases the metabolism of the antipsychotic, leading to increased plasma
concentrations. [CORRECT]
B. The inhibitor increases the metabolism of the antipsychotic, leading to subtherapeutic levels.
C. The inhibitor decreases the absorption of the antipsychotic.
D. The inhibitor increases the protein binding of the antipsychotic.
Correct Answer: A
, 4
Rationale: CYP3A4 inhibitors block the enzyme responsible for breaking down the drug. This
leads to decreased clearance and increased plasma concentrations of the substrate drug (the
antipsychotic), potentially causing toxicity. This is a drug-drug interaction. Increasing
metabolism (B) would be the effect of an inducer.
Q7: Which of the following neurotransmitters is considered the major excitatory neurotransmitter
in the CNS and is the target of memantine (Namenda) in Alzheimer's disease?
A. GABA
C. Glutamate [CORRECT]
B. Glycine
D. Serotonin
Correct Answer: C
Rationale: Glutamate acts on NMDA, AMPA, and kainate receptors to mediate fast excitatory
synaptic transmission. Excess glutamate activity (excitotoxicity) is implicated in
neurodegenerative diseases. Memantine is an NMDA receptor antagonist used to moderate this
excitation. GABA (A) is inhibitory.
Q8: The "Volume of Distribution" (Vd) is a pharmacokinetic parameter that describes:
A. The rate at which a drug is eliminated.
B. The theoretical space in the body available to contain the drug. [CORRECT]
C. The amount of drug bound to plasma proteins.
D. The speed of absorption into the bloodstream.
Correct Answer: B
Rationale: Vd relates the amount of drug in the body to the concentration of drug measured in the
plasma. A high Vd indicates the drug distributes widely into tissues (e.g., lipophilic drugs like
TCAs), while a low Vd suggests the drug remains mostly in the plasma (e.g., warfarin).
NSG 552 Psychopharmacology Exam 1 2 3 Wilkes
University Actual Exam 2026/2027 – Complete Exam-
Style Questions with Detailed Rationales | Pass
Guaranteed – A+ Graded
[EXAM 1: Neuropharmacology & Basic Principles — Questions 1-50]
Q1: Which of the following best describes the primary function of the synaptic cleft in
neurotransmission?
A. To synthesize neurotransmitters.
B. To store vesicles until release.
C. To allow diffusion of neurotransmitters from the presynaptic neuron to the postsynaptic
neuron. [CORRECT]
D. To degrade neurotransmitters via enzymatic breakdown.
Correct Answer: C
Rationale: The synaptic cleft is the physical gap between the presynaptic terminal button and the
postsynaptic membrane. Its primary function is to allow the neurotransmitter, once released, to
diffuse across to bind to receptors on the postsynaptic neuron. Synthesis occurs in the
soma/terminal (A); storage occurs in vesicles (B); degradation (D) occurs primarily in the cleft or
via reuptake, not as the structural purpose of the cleft itself.
Q2: A 28-year-old patient presents with a resting tremor, rigidity, and bradykinesia. Degeneration
of which specific dopamine pathway is most implicated in these symptoms?
A. Nigrostriatal pathway [CORRECT]
B. Mesolimbic pathway
C. Mesocortical pathway
D. Tuberoinfundibular pathway
Correct Answer: A
,2
Rationale: The nigrostriatal pathway projects from the substantia nigra to the basal ganglia and is
responsible for motor control. Degeneration of this pathway leads to the classic extrapyramidal
symptoms (EPS) seen in Parkinson's disease. The mesolimbic (B) is associated with reward and
psychosis; the mesocortical (C) with cognition and affect; the tuberoinfundibular (D) regulates
prolactin.
Q3: Which of the following correctly differentiates ionotropic receptors from metabotropic
receptors?
A. Ionotropic receptors are slow and use second messengers; metabotropic are fast and ligand-
gated.
B. Ionotropic receptors form an ion channel and produce fast synaptic transmission;
metabotropic receptors use G-proteins and second messengers for slower modulation.
[CORRECT]
C. Both receptors utilize second messenger systems.
D. Ionotropic receptors are primarily located presynaptically.
Correct Answer: B
Rationale: Ionotropic receptors (e.g., NMDA, GABA-A) are ligand-gated ion channels that allow
immediate ion flow across the membrane when a neurotransmitter binds, resulting in fast
synaptic transmission. Metabotropic receptors (e.g., GABA-B, 5-HT1A) are linked to G-proteins
and second messenger systems, producing slower, longer-lasting modulatory effects.
Q4: A PMHNP is treating a patient with depression. Which neurotransmitter is primarily
synthesized from the amino acid tryptophan and is heavily implicated in mood, sleep, and
appetite regulation?
A. Dopamine
B. Norepinephrine
C. Serotonin (5-HT) [CORRECT]
D. Acetylcholine
Correct Answer: C
,3
Rationale: Serotonin (5-HT) is synthesized from tryptophan. It plays a critical role in regulating
mood, anxiety, sleep, appetite, and impulse control. Dopamine (A) is synthesized from tyrosine;
Norepinephrine (B) is also synthesized from tyrosine; Acetylcholine (D) is synthesized from
choline and acetyl-CoA.
Q5: Which of the following CYP450 enzymes is responsible for the metabolism of the majority
of antidepressants and is known for its genetic polymorphism resulting in poor and ultrarapid
metabolizers?
A. CYP1A2
C. CYP2D6 [CORRECT]
B. CYP2C9
D. CYP3A4
Correct Answer: C
Rationale: CYP2D6 is highly polymorphic, with significant percentages of the population being
poor metabolizers (PMs) or ultrarapid metabolizers (UMs). It metabolizes many TCAs, SSRIs
(paroxetine, fluoxetine), and antipsychotics. CYP3A4 (D) is the most abundant but less
polymorphic; CYP1A2 (A) and CYP2C9 (B) have fewer substrates relevant to
psychopharmacology.
Q6: A patient prescribed a medication that is a strong CYP3A4 inhibitor (e.g., ketoconazole) is
experiencing toxicity from their existing antipsychotic. What is the pharmacokinetic
explanation?
A. The inhibitor decreases the metabolism of the antipsychotic, leading to increased plasma
concentrations. [CORRECT]
B. The inhibitor increases the metabolism of the antipsychotic, leading to subtherapeutic levels.
C. The inhibitor decreases the absorption of the antipsychotic.
D. The inhibitor increases the protein binding of the antipsychotic.
Correct Answer: A
, 4
Rationale: CYP3A4 inhibitors block the enzyme responsible for breaking down the drug. This
leads to decreased clearance and increased plasma concentrations of the substrate drug (the
antipsychotic), potentially causing toxicity. This is a drug-drug interaction. Increasing
metabolism (B) would be the effect of an inducer.
Q7: Which of the following neurotransmitters is considered the major excitatory neurotransmitter
in the CNS and is the target of memantine (Namenda) in Alzheimer's disease?
A. GABA
C. Glutamate [CORRECT]
B. Glycine
D. Serotonin
Correct Answer: C
Rationale: Glutamate acts on NMDA, AMPA, and kainate receptors to mediate fast excitatory
synaptic transmission. Excess glutamate activity (excitotoxicity) is implicated in
neurodegenerative diseases. Memantine is an NMDA receptor antagonist used to moderate this
excitation. GABA (A) is inhibitory.
Q8: The "Volume of Distribution" (Vd) is a pharmacokinetic parameter that describes:
A. The rate at which a drug is eliminated.
B. The theoretical space in the body available to contain the drug. [CORRECT]
C. The amount of drug bound to plasma proteins.
D. The speed of absorption into the bloodstream.
Correct Answer: B
Rationale: Vd relates the amount of drug in the body to the concentration of drug measured in the
plasma. A high Vd indicates the drug distributes widely into tissues (e.g., lipophilic drugs like
TCAs), while a low Vd suggests the drug remains mostly in the plasma (e.g., warfarin).
